Hughes & Company invests in lower middle market healthcare software and technology-enabled service companies where we see the potential to create substantial value through revenue and EBITDA growth. The Firm is an active investor and works closely with its portfolio companies on initiatives to accelerate growth, expand margins, enhance customer value propositions and increase long-term retention by applying institutional best practices and disciplined execution. The Firm maintains an extensive network of longstanding relationships with senior executives, advisors and partners across the healthcare software and technology-enabled service market who assist Hughes & Company and its portfolio companies in a range of capacities.
“Hughes & Company was a consummate and tireless partner for Aldera. They played an instrumental role in driving value and creating a positive outcome for shareholders and management.”
“Hughes & Company believes in achieving results together through shared experience, perspective, and vision. They are thoughtful partners, helping us drive the best outcomes for our clients and shareholders by complementing our Executive team.”
“Our experience working with Hughes & Company has been great so far. They took the time necessary to assure we had a good match by getting to know our team, understanding our vision, exploring our strengths and weaknesses and getting a feel for our style. I believe we have found the right partner for us and I am confident that our relationship will yield amazing results.”
“When I think of Hughes & Company, I think action. They jump right in, working with you to solve problems, large or small. It’s all about getting things done in a thoughtful, practical and strategic manner.”
Testimonials and/or endorsements of portfolio company executives are provided to demonstrate the benefits of working with the Hughes & Company team. They are not provided to solicit investors in a Hughes & Company fund. Some executives featured in the testimonials or endorsements have an interest in a Hughes & Company fund; such executive’s testimonial or endorsement is not offered on the basis of being an investor in a Hughes & Company fund but rather as an executive who works with the Hughes & Company team. Additionally, Hughes & Company executives are compensated for their work with Hughes & Company but not for their testimonial or endorsement. There is a conflict of interest in these unpaid testimonials and endorsements in that the executives stand to benefit from Hughes & Company’s success and are thus incented to provide favorable references.
